Literature DB >> 9122194

The structure of mitogen-activated protein kinase p38 at 2.1-A resolution.

Z Wang1, P C Harkins, R J Ulevitch, J Han, M H Cobb, E J Goldsmith.   

Abstract

The structure of mitogen-activated protein (MAP) kinase p38 has been solved at 2.1-A to an R factor of 21.0%, making p38 the second low activity MAP kinase solved to date. Although p38 is topologically similar to the MAP kinase ERK2, the phosphorylation Lip (a regulatory loop near the active site) adopts a different fold in p38. The peptide substrate binding site and the ATP binding site are also different from those of ERK2. The results explain why MAP kinases are specific for different activating enzymes, substrates, and inhibitors. A model presented for substrate and activator interactions has implications for the evolution of protein kinase cascades.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122194      PMCID: PMC20087          DOI: 10.1073/pnas.94.6.2327

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

Review 1.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

2.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

3.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

4.  An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control.

Authors:  T G Boulton; G D Yancopoulos; J S Gregory; C Slaughter; C Moomaw; J Hsu; M H Cobb
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

5.  Extracellular signal-regulated kinases 2 autophosphorylates on a subset of peptides phosphorylated in intact cells in response to insulin and nerve growth factor: analysis by peptide mapping.

Authors:  D J Robbins; M H Cobb
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

6.  Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein.

Authors:  A S Zervos; L Faccio; J P Gatto; J M Kyriakis; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase.

Authors:  I Clark-Lewis; J S Sanghera; S L Pelech
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

8.  Crystal structure of the tyrosine kinase domain of the human insulin receptor.

Authors:  S R Hubbard; L Wei; L Ellis; W A Hendrickson
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

9.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.

Authors:  J Han; J D Lee; L Bibbs; R J Ulevitch
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

10.  JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.

Authors:  T Kallunki; B Su; I Tsigelny; H K Sluss; B Dérijard; G Moore; R Davis; M Karin
Journal:  Genes Dev       Date:  1994-12-15       Impact factor: 11.361

View more
  73 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

Authors:  Natalie B Vinh; Jamie S Simpson; Peter J Scammells; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2012-04-20       Impact factor: 3.686

Review 3.  MAPK machinery in plants: recognition and response to different stresses through multiple signal transduction pathways.

Authors:  Gohar Taj; Payal Agarwal; Murray Grant; Anil Kumar
Journal:  Plant Signal Behav       Date:  2010-11-01

Review 4.  Unique MAP Kinase binding sites.

Authors:  Radha Akella; Thomas M Moon; Elizabeth J Goldsmith
Journal:  Biochim Biophys Acta       Date:  2007-11-19

Review 5.  Substrate and docking interactions in serine/threonine protein kinases.

Authors:  Elizabeth J Goldsmith; Radha Akella; Xiaoshan Min; Tianjun Zhou; John M Humphreys
Journal:  Chem Rev       Date:  2007-10-19       Impact factor: 60.622

6.  VSDMIP: virtual screening data management on an integrated platform.

Authors:  Rubén Gil-Redondo; Jorge Estrada; Antonio Morreale; Fernando Herranz; Javier Sancho; Angel R Ortiz
Journal:  J Comput Aided Mol Des       Date:  2008-10-22       Impact factor: 3.686

7.  Nuclear translocation of activated MAP kinase is developmentally regulated in the developing Drosophila eye.

Authors:  Justin P Kumar; Frank Hsiung; Maureen A Powers; Kevin Moses
Journal:  Development       Date:  2003-08       Impact factor: 6.868

8.  Combination of two activating mutations in one HOG1 gene forms hyperactive enzymes that induce growth arrest.

Authors:  Gilad Yaakov; Michal Bell; Stefan Hohmann; David Engelberg
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  The structure of the MAP2K MEK6 reveals an autoinhibitory dimer.

Authors:  Xiaoshan Min; Radha Akella; Haixia He; John M Humphreys; Susan E Tsutakawa; Seung-Jae Lee; John A Tainer; Melanie H Cobb; Elizabeth J Goldsmith
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

10.  A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.

Authors:  T Fox; J T Coll; X Xie; P J Ford; U A Germann; M D Porter; S Pazhanisamy; M A Fleming; V Galullo; M S Su; K P Wilson
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.